FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2137638430> ?p ?o ?g. }

• W2137638430 endingPage "34" @default.
• W2137638430 startingPage "29" @default.
• W2137638430 abstract "Reviews in Medical VirologyVolume 2, Issue 1 p. 29-34 Forum Viral cofactors in acquired immune deficiency syndrome Alison Webster, Alison Webster Department of Virology, Royal Free Hampstead NHS Trust, London NW3, UKSearch for more papers by this author Alison Webster, Alison Webster Department of Virology, Royal Free Hampstead NHS Trust, London NW3, UKSearch for more papers by this author First published: March 1992 https://doi.org/10.1002/rmv.1980020105Citations: 7AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Gendelman, H. E., Phelps, W., Feigenbaum, L. et al. (1986). Transactivation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc. Natl. Acad. Sci. USA, 83, 9759– 9763. 2 Davis, M., Kenney, S. C., Kamine, J., Pagano, J. S. and Huang, E. S. (1987). Immediate-early gene region of human cytomegalovirus trans-activates the promoter of human immunodeficiency virus. Proc. Natl. Acad. Sci. USA, 84, 8642– 8646. 3 Lusso, P., Ensoli, B., Markham, P. D. et al. (1989). Productive dual infection of human CD4 + T lymphocytes by HIV-1 and HHV-6. Nature, 337, 370– 373. 4 Kenney, S., Kamine, J., Markovitz, D., Fenrick, R. and Pagano, J. (1988). An Epstein-Barr virus immediate early gene product trans-activates gene expression from the human immunodeficiency virus long terminal repeat. Proc. Natl. Acad. Sci. USA, 85, 1652– 1656. 5 Siddiqui, A., Gaynor, R., Srinivasan, A., Mapoles, J. and Farr, R. W. (1989). Trans-activation of viral enhancers including the long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein. Virology, 169, 479– 484. 6 Siekevitz, M., Josephs, S. F., Dukovitch, M., Peffer, N., Wong-Staal, F. and Greene, W. C. (1987). Activation of the HIV-1 LTR by T cell mitogens and the transacti-vator protein of HTLV 1. Science, 238, 1575– 1578. 7 Rice, A. B. and Matthews, M. B. (1988). Trans-activation of the human immunodeficiency virus long terminal repeat sequences, expressed in an adenovirus vector, by the adenovirus E1A 13S protein. Proc. Natl. Acad. Sci. USA, 85, 4200– 4204. 8 Rando, R. F., Srinivasan, A., Feingold, J., Gonczol, E. and Plotkin, S. (1990). Characterization of multiple molecular interactions between human cytomegalovirus (HCMV) and human immunodeficiency virus type 1 (HIV-1). Virology, 176, 87– 97. 9 Barry, P. A., Pratt-Lowe, E., Unger, R. E. and Luciw, P. A. (1991). Cellular factors regulate transactivation of human immunodeficiency virus type 1. J. Virol., 65, 1392– 1399. 10 Ensoli, B., Lusso, P., Schachter, F. et al. (1989). Human herpes virus-6 increases HIV-1 expression in coinfected T cells via nuclear factors binding to the HIV-1 enhancer. EMBO J., 8, 3019– 3027. 11 Gimble, J. M., Duh, E., Ostrove, J. M., Gendelman, H. E., Max, E. E. and Rabson, A. B. (1988). Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the NF-kappa B/ core enhancer sequence. J. Virol., 62, 4104– 4112. 12 Twu, J. S., Chu, K. and Robinson, W. S. (1989). Hepatitis B virus X gene activates kappa B-like enhancer sequences in the long terminal repeat of human immunodeficiency virus 1. Proc. Natl. Acad. Sci. USA., 86, 5168– 5172. 13 Skolnik, P. R., Kosloff, B. R. and Hirsch, M. S. (1988). Bidirectional interactions between human immunodeficiency virus type 1 and cytomegalovirus. J. Infect. Dis., 157, 508– 514. 14 Ho, W. Z., Harouse, J. M., Rando, R. F., Gonczol, E., Srinivasan, A. and Plotkin, S. A. (1990). Reciprocal enhancement of gene expression and viral replication between human cytomegalovirus and human immunodeficiency virus type 1. J. Gen. Virol., 71, 97– 103. 15 Tada, H., Rappaport, J., Lashgari, M., Amini, S., Wong-Staal, F. and Khalili, K. (1990). Trans-activation fo the JC virus late promotor by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc. Natl. Acad. Sci. USA, 87, 3479– 3483. 16 Rando, R. E., Pellett, P. E., Luciw, P. A., Bohan, C. A. and Srinivasan, (1987). Transactivation of the human immunodeficiency virus by herpesvirus. Oncogene, 1, 13– 18. 17 Tremblay, M., Gornitsky, M. and Wainberg, M. A. (1989). Active replication of human immunodeficiency virus type 1 by peripheral blood mononuclear cells following coincubation with herpesviruses. J. Med. Virol., 29, 109– 114. 18 Casareale, D., Fiala, M., Chang, C. M., Cone, L. A. and Mocarski, E. S. (1989). Cytomegalovirus enhances lysis of HIV-infected T lymphoblasts. Int. J. Cancer, 44, 124– 130. 19 Carrigan, D. R., Knox, K. K. and Tapper, M. A. (1990). Suppression of human immunodeficiency virus type 1 replication by human herpesvirus-6. J. Infect. Dis., 162, 844– 851. 20 Zack, J. A., Cann, A. J., Lugo, J. P. and Chen, I. S. (1988). HIV-1 production from infected peripheral blood T cells after HTLV-1 induced mitogenic stimulation. Science, 240, 1026– 1029. 21 Folks, T. M., Justement, J., Kinter, A., Dinarello, C. A. and Fauci, A. S. (1987). Cytokine-induced expression of HIV 1 in a chronically infected promonocytic cell line. Science, 238, 800– 802. 22 Clouse, K. A., Powell, D., Washington, I. et al. (1989). Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone. J. Immunol., 142, 431– 438. 23 Clouse, K. A., Robbins, P. B., Fernie, B., Ostrove, J. M. and Fauci, A. S. (1989). Viral antigen stimulation of the production of human monokines capable of regulating HIV1 expression. J. Immunol., 143, 470– 475. 24 Pagano, J. S., Kenney, S., Markovitz, D. and Kamine, J. (1988). Epstein Barr virus and interactions with human retroviruses. J. Virol. Methods, 21, 229– 239. 25 Takeda, A., Tuazon, C. U. and Ennis, F. A. (1988). Antibody-enhanced infection by HIV-1 via Fc receptor-mediated entry. Science, 242, 580– 583. 26 McKeating, J. A. & Griffiths, P. D. and Weiss, R. A. (1990). HIV susceptibility conferred to human fibro-blasts by cytomegalovirus-induced Fc receptor. Nature, 343, 659– 661. 27 Lusso, P., DeMaria, A., Malnati, M. et al. (1991). Induction of CD4 and susceptibility to HIV-1 infection in human CD8 + T lymphocytes by human herpesvirus 6. Nature, 349, 533– 535. 28 Lusso, P., Lori, F. and Gallo, R. C. (1990). CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T cell leukaemia viruses. J. Virol., 64, 6341– 6344. 29 Zhu, Z., Chen, S. S. L. and Huang, A. S. (1990). Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J. AIDS, 3, 215– 219. 30 Goedert, J. J., Kessler, C. M., Aledort, L. M. et al. (1989). A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in people with haemophilia. N. Engl. J. Med., 321, 1121– 1148. 31 Steel, C. M., Ludlam, C. A., Beatson, D. et al. (1988). HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet, i, 1185– 1188. 32 Weber, R., Ledergerber, B., Opravil, M., Siegenthaler, W. and Luthy, R. (1990). Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadone. Br. Med. J., 301, 2– 5. 33 Spira, T. J., Bozeman, L. H., Sanderlin, K. C. et al. (1990). Lack of correlation between human herpesvirus-6 infection and the course of human immunodeficiency virus infection. J. Infect. Dis., 161, 567– 570. 34 Webster, A., Lee, C. A., Cook, D. G. et al. (1989). Cytomegalovirus infection and progression towards AIDS in haemophiliacs with human immunodeficiency virus. Lancet, ii, 63– 66. 35 Jackson, J. B., Erice, A., Englund, J. A., Edson, J. R. and Balfour, H. H. (1988). Prevalence of cytomegalovirus antibody in hemophiliacs and homosexuals infected with human immunodeficiency virus type 1. Transfusion, 28, 187– 189. 36 Becherer, P. R., Smiley, M. L., Matthews, T. J., Weinhold, K. J., McMillan, C. W. and White, G. C. (1990). Human immunodeficiency virus-1 disease progression in hemophiliacs. Am. J. Hematol., 34 (3), 204– 209. 37 Lang, D. J., Kovacs, A. A., Zaia, J. A. et al. (1989). Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. J. AIDS, 2, 540– 549. 38 Frenkel, L. D., Gaur, S., Tsolia, M., Scudder, R., Howell, R. and Kesarwala, H. (1990). Cytomegalovirus infection in children with AIDS. Rev. Infect. Dis., 12 Suppl 7, S820– 826. 39 Margalith, M., Sarov, B., Sarov, I. et al. (1990). Serum IgG and IgA antibodies specific to Epstein-Barr virus capsid antigen in a longitudinal study of human immunodeficiency virus infection and disease progression in homosexual men. AIDS Res. Hum. Retroviruses, 6, 607– 616. 40 Chavanet, P., Malet, J., Waldner, A. et al. (1990). A double blind randomized placebo trial on very high doses of acyclovir in weakly symptomatic HIV-patients. Cancer Detect. Prev., 14, 669– 673. 41 Lee, H. A., Weiss, S. H., Brown, L. S. et al. (1990). Patterns of HIV-1 and HTLV-1/II in intravenous drug abusers from the middle atlantic and central regions of the USA. J. Infect. Dis., 162, 347– 352. 42 Page, J. B., Lai, S., Chitwood, D. D., Klimas, N. G., Smith, P. C. and Fletcher, M. A. (1990). HTLV-1/II seropositivity and death from AIDS among HIV-1 seropositive intravenous drug users. Lancet, i, 1439– 1441. 43 Bartholomew, C., Blattner, W. and Cleghom, F. (1987). Progression to AIDS in homosexual men co-infected with HIV and HTLV-1 in Trinidad. Lancet, 2, 1469. 44 Solomon, R. E., Van Raden, M., Kaslow, R. A. et al. (1990). Association of hepatitis B surface antigen and core antibody with acquisition and manifestations of human immunodeficiency virus type 1 (HIV 1) infection. Am. J. Public Health, 80, 1475– 1478. Citing Literature Volume2, Issue1March 1992Pages 29-34 ReferencesRelatedInformation" @default.
• W2137638430 created "2016-06-24" @default.
• W2137638430 creator A5012527513 @default.
• W2137638430 date "1992-03-01" @default.
• W2137638430 modified "2023-09-23" @default.
• W2137638430 title "Viral cofactors in acquired immune deficiency syndrome" @default.
• W2137638430 cites W1490544683 @default.
• W2137638430 cites W176213802 @default.
• W2137638430 cites W1892302877 @default.
• W2137638430 cites W1904389193 @default.
• W2137638430 cites W1970121767 @default.
• W2137638430 cites W1974593011 @default.
• W2137638430 cites W1975016983 @default.
• W2137638430 cites W1980496424 @default.
• W2137638430 cites W1987260737 @default.
• W2137638430 cites W1992789330 @default.
• W2137638430 cites W2003432695 @default.
• W2137638430 cites W2022329288 @default.
• W2137638430 cites W2026156952 @default.
• W2137638430 cites W2028683817 @default.
• W2137638430 cites W2031891917 @default.
• W2137638430 cites W2036890038 @default.
• W2137638430 cites W2043426227 @default.
• W2137638430 cites W2048671183 @default.
• W2137638430 cites W2052573307 @default.
• W2137638430 cites W2052944144 @default.
• W2137638430 cites W2053706911 @default.
• W2137638430 cites W2059483648 @default.
• W2137638430 cites W2065688863 @default.
• W2137638430 cites W2070661904 @default.
• W2137638430 cites W2070793492 @default.
• W2137638430 cites W2081314460 @default.
• W2137638430 cites W2084895049 @default.
• W2137638430 cites W2094562745 @default.
• W2137638430 cites W2098746214 @default.
• W2137638430 cites W2103264367 @default.
• W2137638430 cites W2107550321 @default.
• W2137638430 cites W2122443059 @default.
• W2137638430 cites W2127923195 @default.
• W2137638430 cites W2143624164 @default.
• W2137638430 cites W2157487869 @default.
• W2137638430 cites W2316380084 @default.
• W2137638430 cites W2331165960 @default.
• W2137638430 doi "https://doi.org/10.1002/rmv.1980020105" @default.
• W2137638430 hasPublicationYear "1992" @default.
• W2137638430 type Work @default.
• W2137638430 sameAs 2137638430 @default.
• W2137638430 citedByCount "7" @default.
• W2137638430 crossrefType "journal-article" @default.
• W2137638430 hasAuthorship W2137638430A5012527513 @default.
• W2137638430 hasConcept C159047783 @default.
• W2137638430 hasConcept C203014093 @default.
• W2137638430 hasConcept C71924100 @default.
• W2137638430 hasConcept C86803240 @default.
• W2137638430 hasConcept C8891405 @default.
• W2137638430 hasConceptScore W2137638430C159047783 @default.
• W2137638430 hasConceptScore W2137638430C203014093 @default.
• W2137638430 hasConceptScore W2137638430C71924100 @default.
• W2137638430 hasConceptScore W2137638430C86803240 @default.
• W2137638430 hasConceptScore W2137638430C8891405 @default.
• W2137638430 hasIssue "1" @default.
• W2137638430 hasLocation W21376384301 @default.
• W2137638430 hasOpenAccess W2137638430 @default.
• W2137638430 hasPrimaryLocation W21376384301 @default.
• W2137638430 hasRelatedWork W1487857142 @default.
• W2137638430 hasRelatedWork W1702322095 @default.
• W2137638430 hasRelatedWork W1865764402 @default.
• W2137638430 hasRelatedWork W1975114493 @default.
• W2137638430 hasRelatedWork W2118087741 @default.
• W2137638430 hasRelatedWork W2577548098 @default.
• W2137638430 hasRelatedWork W3007075535 @default.
• W2137638430 hasRelatedWork W3031852375 @default.
• W2137638430 hasRelatedWork W3112940496 @default.
• W2137638430 hasRelatedWork W4241494942 @default.
• W2137638430 hasVolume "2" @default.
• W2137638430 isParatext "false" @default.
• W2137638430 isRetracted "false" @default.
• W2137638430 magId "2137638430" @default.
• W2137638430 workType "article" @default.